540 related articles for article (PubMed ID: 28478507)
41. Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance.
Shi Y; Guryanova OA; Zhou W; Liu C; Huang Z; Fang X; Wang X; Chen C; Wu Q; He Z; Wang W; Zhang W; Jiang T; Liu Q; Chen Y; Wang W; Wu J; Kim L; Gimple RC; Feng H; Kung HF; Yu JS; Rich JN; Ping YF; Bian XW; Bao S
Sci Transl Med; 2018 May; 10(443):. PubMed ID: 29848664
[TBL] [Abstract][Full Text] [Related]
42. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
[TBL] [Abstract][Full Text] [Related]
43. MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy.
Hsu TI; Lin SC; Lu PS; Chang WC; Hung CY; Yeh YM; Su WC; Liao PC; Hung JJ
Oncogene; 2015 Feb; 34(7):826-37. PubMed ID: 24632608
[TBL] [Abstract][Full Text] [Related]
44. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
[TBL] [Abstract][Full Text] [Related]
45. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
[TBL] [Abstract][Full Text] [Related]
46. Interaction of NF-κB and FOSL1 drives glioma stemness.
Ramar V; Guo S; Hudson B; Khedri A; Guo AA; Li J; Liu M
Cell Mol Life Sci; 2024 Jun; 81(1):255. PubMed ID: 38856747
[TBL] [Abstract][Full Text] [Related]
47. Down-modulation of SEL1L, an unfolded protein response and endoplasmic reticulum-associated degradation protein, sensitizes glioma stem cells to the cytotoxic effect of valproic acid.
Cattaneo M; Baronchelli S; Schiffer D; Mellai M; Caldera V; Saccani GJ; Dalpra L; Daga A; Orlandi R; DeBlasio P; Biunno I
J Biol Chem; 2014 Jan; 289(5):2826-38. PubMed ID: 24311781
[TBL] [Abstract][Full Text] [Related]
48. Transcriptional CDK Inhibitors CYC065 and THZ1 Induce Apoptosis in Glioma Stem Cells Derived from Recurrent GBM.
Juric V; Düssmann H; Lamfers MLM; Prehn JHM; Rehm M; Murphy BM
Cells; 2021 May; 10(5):. PubMed ID: 34066147
[TBL] [Abstract][Full Text] [Related]
49. PLK1 inhibitor facilitates the suppressing effect of temozolomide on human brain glioma stem cells.
Liu N; Hu G; Wang H; Li Z; Guo Z
J Cell Mol Med; 2018 Nov; 22(11):5300-5310. PubMed ID: 30133120
[TBL] [Abstract][Full Text] [Related]
50. Epigenetic modulator inhibition overcomes temozolomide chemoresistance and antagonizes tumor recurrence of glioblastoma.
Moon BS; Cai M; Lee G; Zhao T; Song X; Giannotta SL; Attenello FJ; Yu M; Lu W
J Clin Invest; 2020 Nov; 130(11):5782-5799. PubMed ID: 33016927
[TBL] [Abstract][Full Text] [Related]
51. The Role Played by SLUG, an Epithelial-Mesenchymal Transition Factor, in Invasion and Therapeutic Resistance of Malignant Glioma.
Oh SJ; Ahn EJ; Kim O; Kim D; Jung TY; Jung S; Lee JH; Kim KK; Kim H; Kim EH; Lee KH; Moon KS
Cell Mol Neurobiol; 2019 Aug; 39(6):769-782. PubMed ID: 31011939
[TBL] [Abstract][Full Text] [Related]
52. The Interleukin-33/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation.
Lin L; Li Y; Liu M; Li Q; Liu Q; Li R
Aging (Albany NY); 2020 Jan; 12(2):1685-1703. PubMed ID: 32003751
[TBL] [Abstract][Full Text] [Related]
53. Novel INHAT repressor drives glioblastoma growth by promoting ribosomal DNA transcription in glioma stem cells.
Tao W; Lei H; Luo W; Huang Z; Ling P; Guo M; Wan L; Zhai K; Huang Q; Wu Q; Xu S; Zeng L; Wang X; Dong Z; Rich JN; Bao S
Neuro Oncol; 2023 Aug; 25(8):1428-1440. PubMed ID: 36521011
[TBL] [Abstract][Full Text] [Related]
54. Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance.
Kostopoulou ON; Mohammad AA; Bartek J; Winter J; Jung M; Stragliotto G; Söderberg-Nauclér C; Landázuri N
Int J Cancer; 2018 Mar; 142(6):1266-1276. PubMed ID: 29067692
[TBL] [Abstract][Full Text] [Related]
55. Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway.
Zang J; Zheng MH; Cao XL; Zhang YZ; Zhang YF; Gao XY; Cao Y; Shi M; Han H; Liang L
Cell Commun Signal; 2020 Aug; 18(1):135. PubMed ID: 32843056
[TBL] [Abstract][Full Text] [Related]
56. LncRNA GSCAR promotes glioma stem cell maintenance via stabilizing SOX2 expression.
Jiang X; Zhang Y; Yuan Y; Jin Z; Zhai H; Liu B; Li Y; Zhang C; Chen M; Shi Y; Yan D; Pu J; Chen Y; Yang C
Int J Biol Sci; 2023; 19(6):1681-1697. PubMed ID: 37063420
[TBL] [Abstract][Full Text] [Related]
57. Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.
Yoo YD; Lee DH; Cha-Molstad H; Kim H; Mun SR; Ji C; Park SH; Sung KS; Choi SA; Hwang J; Park DM; Kim SK; Park KJ; Kang SH; Oh SC; Ciechanover A; Lee YJ; Kim BY; Kwon YT
EMBO Rep; 2017 Jan; 18(1):150-168. PubMed ID: 27993939
[TBL] [Abstract][Full Text] [Related]
58. CDK5 Inhibition Resolves PKA/cAMP-Independent Activation of CREB1 Signaling in Glioma Stem Cells.
Mukherjee S; Tucker-Burden C; Kaissi E; Newsam A; Duggireddy H; Chau M; Zhang C; Diwedi B; Rupji M; Seby S; Kowalski J; Kong J; Read R; Brat DJ
Cell Rep; 2018 May; 23(6):1651-1664. PubMed ID: 29742423
[TBL] [Abstract][Full Text] [Related]
59. NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn.
Guo S; Ran H; Xiao D; Huang H; Mi L; Wang X; Chen L; Li D; Zhang S; Han Q; Zhou T; Li A; Man J
Cancer Lett; 2019 Jul; 454():98-107. PubMed ID: 30978441
[TBL] [Abstract][Full Text] [Related]
60. UCHL3 induces radiation resistance and acquisition of mesenchymal phenotypes by deubiquitinating POLD4 in glioma stem cells.
Fan L; You H; Jiang X; Niu Y; Chen Z; Wang H; Xu Y; Zhou P; Wei L; Jiang T; Deng D; Xue L; Peng Y; Xing W; Shao N
Cell Mol Life Sci; 2024 Jun; 81(1):247. PubMed ID: 38829550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
